University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 2 of 26
Microbiome in Head and Neck Squamous Cell Carcinoma
NCT05837221
Smart Underwear to Measure Diet-Induced Hydrogen Sulfide Production
NCT06802276
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
NCT07424365
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
NCT06349577
Project Safe Guard-Trauma
NCT06876740
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
NCT06953375
The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home
NCT06467916
Alcohol and Sexual Communication Among Couples in the Laboratory
NCT06865872
Semiconductor Embedded Socks for Ankle Sprains
NCT07025733
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
NCT06239844
Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt
NCT07553962
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
NCT06582875
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
NCT06860633
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
NCT06526988
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
NCT06686537
Evaluating the Reach of Clinical Decision Support for Patients With Heart Failure
NCT06847906
A Novel Imaging Modality to Evaluate Radiation-Induced Uterine Injury
NCT06518174
ALIGN for Older Adults With Cancer in SNFs
NCT06616298
BfedBwell Optimization Pilot
NCT06184256
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
NCT06656676
Practice Facilitation to Enhance Implementation of a Pediatric Suicide Prevention Pathway
NCT06619782
Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery
NCT06641271
Thermogenenic Responses to Fasting and Overfeeding in Women
NCT06610162
Puberty, Testosterone, and Brain Development
NCT06670053
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
NCT06705387
A Study of Cannabidiol in Young Adult Cannabis Users
NCT06569394
UNderstanding the Causes Of Idiopathic Scoliosis Through the Longitudinal Analysis of Proteomic Markers: the UNCOIL Study
NCT07634627
Cannabidiol and Cannabis Concentrate Users
NCT06575751
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
NCT06379971
Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems
NCT06575790
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
NCT06430541
Innovations in Hearing Accessibility and Technology (IHAT) Study
NCT06689865
Corticosteroids for Post-Extubation Dysphagia
NCT06670521
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
NCT06693622
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
NCT05832307
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
NCT06598449
Stop, Focus, Plan, and Change: Predicting Parent and Child Responses to a Brief, Telehealth Parent Training
NCT06505980
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
NCT06575738
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
NCT06414096
Lynch Syndrome Integrative Epidemiology and Genetics
NCT06582914
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
NCT06559189
An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans
NCT06587113
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
NCT06320366
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
NCT06296810
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
NCT06493825
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
NCT06501118
Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes
NCT06575842
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
NCT07009509
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
NCT06529406
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
NCT06429449
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.